Evidence map›Paper›PMID 31694615›Full record

ArticleBMC complementary and alternative medicine2019

Identification and characterization of the Cucurbitacins, a novel class of small-molecule inhibitors of Tropomyosin receptor kinase a.

Yueling Zhong, Hong Xu, Yi Zhong, Xuemiao Zhang, Ting Zeng, Limei Li, Gaojie Xu, Minhui Li, Jin Liu, Tai Yang

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Emerging Therapeutic Options for Chronic Pruritus.American journal of clinical dermatology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yueling ZhongSchool of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China.
Hong XuSchool of Laboratory Medicine, Chengdu Medical College, Chengdu, China.
Yi ZhongSchool of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China.
Xuemiao ZhangSchool of Laboratory Medicine, Chengdu Medical College, Chengdu, China.
Ting ZengCenter for Scientific Research, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Sichuan Province, China.
Limei LiSchool of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China.
Gaojie XuSchool of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China.
Minhui LiCenter for Scientific Research, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Sichuan Province, China.
Jin LiuSchool of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China. jinliu@cmc.edu.cn.
Tai YangSchool of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China. taiyang@cmc.edu.cn.ORCID http://orcid.org/0000-0002-5606-325X
Chengdu Medical College · CN

Funding

Chengdu Science and Technology Bureau 2015-HM01-00506-SFNational Undergraduates Innovating Experimentation Project 201613705009, 201613705070, 201613705092Scientific Research Fund of Chengdu Medical College NO. CYCG15-01Scientific Research Fund of CMA - L'OREAL China Skin/Hair S2016-25Scientific Research Fund of the National Natural Science Foundation of China NO. 81201668Scientific Research Fund of the Sichuan Provincial Education Department NO. 17CZ0011, 17ZA0109
6 · The paper itself

Abstract

backgroundNGF-TrkA is well known to play a key role in propagating and sustaining pruritogenic signals, which form the pathology of chronic pruritus. Inhibition of NGF-TrkA is a known strategy for the treatment of pruritus. In the present paper, we describe the identification, in vitro characterization, structure-activity analysis, and inhibitory evaluation of a novel TrkA inhibitory scaffold exemplified by Cucurbitacins (Cus).

methodsCus were identified as TrkA inhibitors in a large-scale kinase library screen. To obtain structural models of Cus as TrkA inhibitors, AutoDock was used to explore their binding to TrkA. Furthermore, PC12 cell culture systems have been used to study the effects of Cus and traditional Chinese medicinal plants (Tian Gua Di and bitter gourd leaf) extracts on the kinase activity of TrkA.

resultsCus block the phosphorylation of TrkA on several tyrosine sites, including Tyr490, Tyr674/675, and Tyr785, and inhibit downstream Akt and MAPK phosphorylation in response to NGF in PC12 cell model systems. Furthermore, traditional Chinese medicinal plants (Tian Gua Di and bitter gourd leaf) containing Cu extracts were shown to inhibit the phosphorylation of TrkA and Akt. These data reveal mechanisms, at least partly, of the anti-pruritus bioactivity of Cus.

conclusionTaken together, with the recent discovery of the important role of TrkA as a therapeutic target, Cus could be the basis for the design of improved TrkA kinase inhibitors, which could someday help treat pruritus.

Indexed as

Amino Acid MotifsAnimalsCucumis meloCucurbitacinsEnzyme InhibitorsFruitHumansKineticsMomordica charantiaNerve Growth FactorPC12 CellsPhosphorylationPlant ExtractsRatsReceptor, trkACucurbitacinsEnzyme InhibitorsNerve Growth FactorPlant ExtractsReceptor, trkACucurbitacinsInhibitorsKinasePruritusTrkA

Identifiers

PMID31694615
PMCPMC6836411
OpenAlexW2986887699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.